Virginie Durez, MSc, MBA, PMP®
Senior Director, Product Development & Project ManagementVirginie joined Neuren in 2021 and brings over twenty years of global pharmaceutical experience ranging from product ideation to product launch. Prior to joining Neuren, she worked with Pfizer for seventeen years through the legacy of Hospira and Mayne Pharma, in the Program Management, Commercial and Early Stage Development Groups and most recently worked as the Pipeline Development Lead for the Hospital Business Unit. Virginie has assessed, developed, and led over 100 global product strategies (US, EU, CAN, ANZ, China and Japan) and launched 3 products to the market. She is focused on bringing novel therapies that change patients’ lives. Virginie received her Master of Chemistry and her Master of Chemical Engineering in France (University of Aix-Marseilles and Ecole Nationale Supérieure de Chimie de Toulouse), earned an MBA from the Australian Graduate School of Entrepreneurship, and is a PMP® practitioner.
- Forums
- ASX - By Stock
- Acadia
Virginie Durez, MSc, MBA, PMP®Senior Director, Product...
-
- There are more pages in this discussion • 620 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.18 |
Change
-0.300(1.94%) |
Mkt cap ! $1.940B |
Open | High | Low | Value | Volume |
$15.20 | $15.33 | $15.02 | $3.046M | 200.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 401 | $15.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.20 | 355 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 206 | 15.210 |
11 | 792 | 15.200 |
7 | 761 | 15.190 |
4 | 505 | 15.180 |
4 | 466 | 15.170 |
Price($) | Vol. | No. |
---|---|---|
15.230 | 1599 | 9 |
15.240 | 827 | 12 |
15.250 | 514 | 5 |
15.260 | 1688 | 7 |
15.270 | 384 | 4 |
Last trade - 12.14pm 22/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |